AHA GUIDELINES Bundle (free trial)

Lower Extremity Peripheral Artery Disease 2024

AHA GUIDELINES Apps brought to you courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1521560

Contents of this Issue

Navigation

Page 26 of 55

27 Low-dose aspirin + rivaroxaban 2.5 mg BID (1) DAPT: low-dose aspirin + P2Y12 inhibitor after endovascular revascularization (2a) SAPT with full intensity anticoagulation (if needed for AFIB, VTE, or other indication) (2a) DAPT: low-dose aspirin + P2Y12 inhibitor after surgical revascularization with a prosthetic graft (2b) Recent revascularization (endovascular or surgical) Antiplatelet and antithrombotic therapy (1) Cardiovascular risk reduction (lipid-lowering, antihypertensive therapy, diabetes management) (1) Smoking cessation (1) Cilostazol (chronic symptomatic PAD) (1) Influenza and SARS-CoV-2 vaccination (1) Structured exercise (chronic symptomatic PAD) (1) Preventive foot care (chronic symptomatic PAD) (1) Wound care, pressure offloading, management of infection (CLTI) (1) Symptomatic PAD (Chronic symptomatic, including claudication, and CLTI) Antiplatelet and antithrombotic therapy

Articles in this issue

Archives of this issue

view archives of AHA GUIDELINES Bundle (free trial) - Lower Extremity Peripheral Artery Disease 2024